Datar Cancer Genetics Limited
Tim Courtemarche is an experienced sales and business development professional with a strong background in the medical and biotechnology sectors. Currently serving as Area Sales Director at Datar Cancer Genetics Limited since January 2022, Tim contributes to a leading molecular oncology facility that boasts extensive laboratory capabilities and accreditations. Previous roles include Business Development at Octusa Spine\Enosight A.I. and founder of Octusa Spine, where Tim established a successful medical distributorship. Tim also gained valuable experience in sales at Integra LifeSciences and Biomet, focusing on spine and neuro products. Educational qualifications include a Bachelor of Business Administration from California State Polytechnic University-Pomona and an Associate of Arts from Mt. San Antonio College.
This person is not in any teams
This person is not in any offices
Datar Cancer Genetics Limited
We are a World-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting. The facility is NABL, ISO, CAP and CLIA accredited. National and international cancer research institutes, and patients from all over the world including US, Switzerland, Germany and UK avail our services. With the help of latest technology and several years of extensive research, we offer highly effective treatment solutions to cancer patients for whom, multiple lines of treatment have failed. Our state-of-the-art cancer research centre is spread over 40,000 sq.ft. with a formidable team of cancer researchers, doctors, scientists and other technologists educated and trained at top universities and institutes around the world. Our entire team is always at the disposal of clinicians and cancer patients to bring cutting-edge treatment options in the most challenging cases.